Avista Healthcare Partners sells Solmetex, a dental products provider, to AGIC Capital, marking a successful exit after four years.

Recess secures $1.75M in pre-seed funding to launch a marketplace for parents to book children's enrichment classes and activities.

Former flight attendant Brenda Phipps grows three Batteries Plus stores in Florida to over $3 million in annual sales.

Global wearable tech market to grow from $218.27B in 2024 to $885.65B by 2033, with smartwatches leading shipments at 180M units in 2024.

Cyrano Therapeutics partners with Resyca for soft mist nasal spray technology to enhance drug delivery for smell loss treatment.

RegCell, a biotech company developing therapies for autoimmune diseases, raises $45.8M and moves headquarters to the U.S. to accelerate growth.

OneD Battery Sciences' SINANODE® technology significantly reduces carbon footprint of EV battery anodes, according to Minviro LCA report.

Lorient Capital, a healthcare-focused private investment firm, adds Stephanie DeGennaro as General Counsel and John Cotcher as VP of Compliance and HR Ops.

Muinzer recapitalizes 1,356-bed student housing portfolio near University of Tennessee, partnering with Kayne Anderson Real Estate.

West Monroe partners with ServiceNow to optimize customer service operations, leveraging industry expertise for faster value realization.

Nimblemind.ai secures $2.5M funding to accelerate its AI-powered data infrastructure platform for healthcare providers.

Accropeutics raises $12M in Series B Plus funding led by Shenzhen Capital Group, extending cash runway into second half of 2026.

Porter secures investment from Eir Partners to expand AI-driven care coordination services for improved patient outcomes and risk adjustment.

Eir Partners invests in Porter, a healthcare IT platform for care coordination, to expand its offerings and improve patient outcomes.

UK-based Celnor Group acquires John Turner Consulting, marking its first international expansion into the US testing and inspection market.

EQT completes placement of 15 million shares in Galderma Group AG, receiving gross proceeds of CHF 354 million from the sale.

Insilico Medicine raises $110M in Series E funding to advance AI-driven drug discovery platform and pipeline development.

Zynext Ventures invests in Illexcor Therapeutics to develop a first-in-class oral drug targeting the root cause of sickle cell disease.

MicroTransponder raises $65M to expand adoption of its FDA-approved Vivistim Paired VNS System for chronic stroke recovery.

Vori Health raises $53M Series B to scale its physician-led musculoskeletal care model, achieving 4:1 ROI and significant clinical outcomes.